The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Open accessAbstract
Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused by a novel coronavirus, SARS-coronavirus (SARS-CoV). The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. In this Review, we highlight recent advances in the development of vaccines and therapeutics based on the S protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Silencing SARS‐CoV Spike protein expression in cultured cells by RNA interference
Zhang, Y., Li, T., Fu, L. L., Yu, C., Li, Y., Xu, X., Wang, Y., Ning, H., Zhang, S., Chen, W., et al. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00087-0 · Cited by 149
RetractedAngiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J. H., Wang, H., Crameri, G., Hu, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,560
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
Guan, Y., Zheng, B. J., He, Y. Q., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S. W., Li, P. H., Zhang, L. J., Guan, Y. J., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,406
Self-citationStructure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,026
Zhong, N., Zheng, B., Li, Y., Poon, L., Xie, Z., Chan, K., Li, P., Tan, S., Chang, Q., Xie, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14630-2 · Cited by 1,579
Self-citationSevere acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y., Tsoi, H.-W., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,544
Chan, D. C., & Kim, P. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81430-0 · Cited by 1,277
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,076
Self-citationInhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,052
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., Laman, J. D., de Jong, T., van Doornum, G., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,020
Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S., Huang, I., Xu, K., Vasilieva, N., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600640 · Cited by 988
Self-citationWild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., & Matthews, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9770 · Cited by 931
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Wong, S. K., Li, W., Moore, M. J., Choe, H., & Farzan, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300520200 · Cited by 694
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K., & Nabel, G. J. (2004) · Nature · doi:10.1038/nature02463 · Cited by 665
Short interfering RNA confers intracellular antiviral immunity in human cells
Gitlin, L., Karelsky, S., & Andino, R. (2002) · Nature · doi:10.1038/nature00873 · Cited by 608
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 605
Pathology and Pathogenesis of Severe Acute Respiratory Syndrome
Gu, J., & Korteweg, C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061088 · Cited by 592
Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L. J., Wong, S. K., Moore, M. J., Tallarico, A. S. C., Olurinde, M., Choe, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307140101 · Cited by 550
Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306446101 · Cited by 543
Jiang, S., Lin, K., Strick, N., & Neurath, A. R. (1993) · Nature · doi:10.1038/365113a0 · Cited by 508
Self-citationLiu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C. R., Xiong, H., Farmar, J., Debnath, A. K., Tien, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15788-7 · Cited by 505
Self-citationYang, Z.-Y., Huang, Y., Ganesh, L., Leung, K., Kong, W.-P., Schwartz, O., Subbarao, K., & Nabel, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5642-5650.2004 · Cited by 490
Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11334-11339.2004 · Cited by 485
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B., Vogel, L., Herman, B. D., Sheahan, T., Heise, M., Genrich, G. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030005 · Cited by 447
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque
Li, B.-J., Tang, Q., Cheng, D., Qin, C., Xie, F. Y., Wei, Q., Xu, J., Liu, Y., Zheng, B.-J., Woodle, M. C., et al. (2005) · Nature Medicine · doi:10.1038/nm1280 · Cited by 433
Self-citationBisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Bosch, B. J., Martina, B. E. E., van der Zee, R., Lepault, J., Haijema, B. J., Versluis, C., Heck, A. J. R., de Groot, R., Osterhaus, A. D. M. E., & Rottier, P. J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400576101 · Cited by 416
Subbarao, K., McAuliffe, J., Vogel, L., Fahle, G., Fischer, S., Tatti, K., Packard, M., Shieh, W.-J., Zaki, S., & Murphy, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 406
He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.106 · Cited by 403
Self-citationA review of studies on animal reservoirs of the SARS coronavirus
Shi, Z., & Hu, Z. (2008) · Virus Research · doi:10.1016/j.virusres.2007.03.012 · Cited by 400
Buchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
The intracellular sites of early replication and budding of SARS-coronavirus
Stertz, S., Reichelt, M., Spiegel, M., Kuri, T., Martínez-Sobrido, L., García-Sastre, A., Weber, F., & Kochs, G. (2007) · Virology · doi:10.1016/j.virol.2006.11.027 · Cited by 382
Huang, I.-C., Bosch, B. J., Li, F., Li, W., Lee, K. H., Ghiran, S., Vasilieva, N., Dermody, T. S., Harrison, S. C., Dormitzer, P. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508381200 · Cited by 375
Structural basis for membrane fusion by enveloped viruses
Weissenhorn, Dessen, Calder, Harrison, Skehel, & Wiley, D. C. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294706 · Cited by 372
The SARS-CoV S glycoprotein: expression and functional characterization
Xiao, X., Chakraborti, S., Dimitrov, A. S., Gramatikoff, K., & Dimitrov, D. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.054 · Cited by 370
Inoue, Y., Tanaka, N., Tanaka, Y., Inoue, S., Morita, K., Zhuang, M., Hattori, T., & Sugamura, K. (2007) · Journal of Virology · doi:10.1128/jvi.00253-07 · Cited by 369
Weingartl, H., Czub, M., Czub, S., Neufeld, J., Marszal, P., Gren, J., Smith, G., Jones, S., Proulx, R., Deschambault, Y., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12672-12676.2004 · Cited by 344
Holmes, K. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmp030078 · Cited by 330
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection
Matsuyama, S., Ujike, M., Morikawa, S., Tashiro, M., & Taguchi, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503203102 · Cited by 315
Bosch, B. J., Bartelink, W., & Rottier, P. J. M. (2008) · Journal of Virology · doi:10.1128/jvi.00415-08 · Cited by 315
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L. E., Prabakaran, P., Rockx, B., Sidorov, I. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701000104 · Cited by 287
Self-citationKubo, H., Yamada, Y. K., & Taguchi, F. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5403-5410.1994 · Cited by 286
Deming, D., Sheahan, T., Heise, M., Yount, B., Davis, N., Sims, A., Suthar, M., Harkema, J., Whitmore, A., Pickles, R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030525 · Cited by 275
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
ter Meulen, J., Bakker, A. B., van den Brink, E. N., Weverling, G. J., Martina, B. E., Haagmans, B. L., Kuiken, T., de Kruif, J., Preiser, W., Spaan, W., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16506-9 · Cited by 265
Bukreyev, A., Lamirande, E. W., Buchholz, U. J., Vogel, L. N., Elkins, W. R., Claire, M. S., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16501-x · Cited by 256
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
Yang, Z.-Y., Werner, H. C., Kong, W.-P., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 253
Crystal Structure of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Fusion Core
Xu, Y., Lou, Z., Liu, Y., Pang, H., Tien, P., Gao, G. F., & Rao, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408782200 · Cited by 252
Kuhn, J. H., Li, W., Choe, H., & Farzan, M. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-004-4242-5 · Cited by 249
Babcock, G. J., Esshaki, D. J., Thomas, W. D., & Ambrosino, D. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4552-4560.2004 · Cited by 243
He, Y., Lu, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 241
Self-citationPrabakaran, P., Gan, J., Feng, Y., Zhu, Z., Choudhry, V., Xiao, X., Ji, X., & Dimitrov, D. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600697200 · Cited by 238
SARS coronavirus and innate immunity
Frieman, M., Heise, M., & Baric, R. (2008) · Virus Research · doi:10.1016/j.virusres.2007.03.015 · Cited by 235
SARS coronavirus: a new challenge for prevention and therapy
Holmes, K. V. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18819 · Cited by 223
Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006) · Virology · doi:10.1016/j.virol.2006.01.029 · Cited by 214
Kam, Y. W., Kien, F., Roberts, A., Cheung, Y. C., Lamirande, E. W., Vogel, L., Chu, S. L., Tse, J., Guarner, J., Zaki, S. R., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.011 · Cited by 210
A model of the ACE2 structure and function as a SARS-CoV receptor
Prabakaran, P., Xiao, X., & Dimitrov, D. S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.081 · Cited by 209
Hofmann, H., Hattermann, K., Marzi, A., Gramberg, T., Geier, M., Krumbiegel, M., Kuate, S., Überla, K., Niedrig, M., & Pöhlmann, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6134-6142.2004 · Cited by 199
Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein Core
Tripet, B., Howard, M. W., Jobling, M., Holmes, R. K., Holmes, K. V., & Hodges, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400759200 · Cited by 198
Identification of a Receptor-Binding Domain of the Spike Glycoprotein of Human Coronavirus HCoV-229E
Bonavia, A., Zelus, B. D., Wentworth, D. E., Talbot, P. J., & Holmes, K. V. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2530-2538.2003 · Cited by 194
Pathogenetic mechanisms of severe acute respiratory syndrome
Guo, Y., Korteweg, C., McNutt, M. A., & Gu, J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.01.022 · Cited by 188
Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., He, T., Yu, W., Yu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2678-2688.2005 · Cited by 183
Du, L., Zhao, G., He, Y., Guo, Y., Zheng, B.-J., Jiang, S., & Zhou, Y. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.10.031 · Cited by 182
Self-citationEvaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
CZUB, M., WEINGARTL, H., CZUB, S., HE, R., & CAO, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.033 · Cited by 180
Severe Acute Respiratory Syndrome (SARS): A Year in Review
Skowronski, D. M., Astell, C., Brunham, R. C., Low, D. E., Petric, M., Roper, R. L., Talbot, P. J., Tam, T., & Babiuk, L. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.091103.134135 · Cited by 173
Qu, X.-X., Hao, P., Song, X.-J., Jiang, S.-M., Liu, Y.-X., Wang, P.-G., Rao, X., Song, H.-D., Wang, S.-Y., Zuo, Y., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500662200 · Cited by 161
Self-citationHan, D. P., Lohani, M., & Cho, M. W. (2007) · Journal of Virology · doi:10.1128/jvi.00315-07 · Cited by 157
Kao, R. Y., Tsui, W. H. W., Lee, T. S. W., Tanner, J. A., Watt, R. M., Huang, J.-D., Hu, L., Chen, G., Chen, Z., Zhang, L., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.07.013 · Cited by 156
van den Brink, E. N., ter Meulen, J., Cox, F., Jongeneelen, M. A. C., Thijsse, A., Throsby, M., Marissen, W. E., Rood, P. M. L., Bakker, A. B. H., Gelderblom, H. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1635-1644.2005 · Cited by 156
Inhibition of SARS-CoV replication by siRNA
Wu, C., Huang, H.-W., Liu, C.-Y., Hong, C.-F., & Chan, Y.-L. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.09.005 · Cited by 153
Sui, J., Li, W., Roberts, A., Matthews, L. J., Murakami, A., Vogel, L., Wong, S. K., Subbarao, K., Farzan, M., & Marasco, W. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.5900-5906.2005 · Cited by 153
Nie, Y., Wang, G., Shi, X., Zhang, H., Yan, Q., Zhong-ping, H., Wei, W., Lian, G., Yin, X., Du, L., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423286 · Cited by 146
Self-citationConformational States of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Ectodomain
Li, F., Berardi, M. J., Li, W., Farzan, M., Dormitzer, P. R., & Harrison, S. C. (2006) · Journal of Virology · doi:10.1128/jvi.02744-05 · Cited by 143
Sáinz, B., Rausch, J. M., Gallaher, W. R., Garry, R. F., & Wimley, W. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7195-7206.2005 · Cited by 138
Du, L., Zhao, G., Lin, Y., Sui, H., Chan, C. C. S., Ma, S., He, Y., Jiang, S., Wu, C. Y., Yuen, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.948 · Cited by 137
Self-citationLiang, G., Chen, Q., Xu, J., Liu, Y., Lim, W. W. L., Peiris, M. J. S., Anderson, L. J., Ruan, L., Li, H., Kan, B., et al. (2004) · Emerging infectious diseases · doi:10.3201/eid1010.040445 · Cited by 136
He, Y., Li, J., Heck, S., Lustigman, S., & Jiang, S. (2006) · Journal of Virology · doi:10.1128/jvi.00083-06 · Cited by 135
Self-citationRockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008) · Journal of Virology · doi:10.1128/jvi.02377-07 · Cited by 134
HIV Entry Inhibitors Targeting gp41: From Polypeptides to Small-Molecule Compounds
Liu, S., Wu, S., & Jiang, S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313722 · Cited by 132
Self-citationDu, L., Kao, R. Y. T., Zhou, Y., He, Y., Zhao, G., Wong, C., Jiang, S., Yuen, K., Jin, D., & Zheng, B.-J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.092 · Cited by 131
Self-citationThe life cycle of SARS coronavirus in Vero E6 cells
Qinfen, Z., Cui, J., Huang, X., Huanying, Z., Jicheng, H., Fang, L., Li, K., & Jingqiang, Z. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20095 · Cited by 131
He, Y., Zhou, Y., Siddiqui, P., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.052 · Cited by 130
Self-citationHe, Y., Li, J., Li, W., Lustigman, S., Farzan, M., & Jiang, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6085 · Cited by 118
Self-citationSuppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein
Yuan, K., Yi, L., Chen, J., Qu, X., Qing, T., Rao, X., Jiang, P., Hu, J., Xiong, Z., Nie, Y., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.046 · Cited by 114
siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication
Li, T., Zhang, Y., Fu, L., Yu, C., Li, X. T., Li, Y., Zhang, X., Rong, Z., Wang, Y., Ning, H., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302479 · Cited by 111
Greenough, T. C., Carville, A., Coderre, J. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., & Mansfield, K. G. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62989-6 · Cited by 111
Roberts, A., Thomas, W. D., Guarner, J., Lamirande, E. W., Babcock, G. J., Greenough, T. C., Vogel, L., Hayes, N., Sullivan, J. L., Zaki, S. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/500143 · Cited by 103
Keng, C. T., Zhang, A., Shen, S., Lip, K.-M., Fielding, B. C., Tan, T. H. P., Chou, C.-F., Loh, C. B., Wang, S., Fu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3289-3296.2005 · Cited by 102
Prophylactic and Therapeutic Effects of Small Interfering Rna Targeting Sars-Coronavirus
Zheng, B., Guan, Y., Tang, Q., Cheng, D., Xie, F. Y., He, M., Chan, K.-W., Wong, K., Lader, E., Woodle, M. C., et al. (2004) · Antiviral Therapy · doi:10.1177/135965350400900310 · Cited by 102
Self-citationHe, Y., Zhu, Q., Liu, S., Zhou, Y., Baoan, Y., Li, J., & Jiang, S. (2005) · Virology · doi:10.1016/j.virol.2005.01.034 · Cited by 100
Self-citationAmiodarone Alters Late Endosomes and Inhibits SARS Coronavirus Infection at a Post-Endosomal Level
Stadler, K., Ha, H. R., Ciminale, V., Spirlı̀, C., Saletti, G., Schiavon, M., Bruttomesso, D., Bigler, L., Folláth, F., Pettenazzo, A., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0217oc · Cited by 99
An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus
Qin, C., Wang, J., Wei, Q., She, M., Marasco, W. A., Jiang, H., Tu, X., Zhu, H., Ren, L., Gao, H., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1769 · Cited by 96
Zhong, X., Yang, H., Guo, Z., Sin, W.-Y. F., Chen, W., Xu, J., Fu, L. L., Wu, J., Mak, C.-K. G., Cheng, C.-S. S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3401-3408.2005 · Cited by 88
Du, L., Zhao, G., Lin, Y., Chan, C. C. S., He, Y., Jiang, S., Wu, C. Y., Jin, D., Yuen, K., Zhou, Y., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.025 · Cited by 86
Self-citationSee, R. H., Petric, M., Lawrence, D. J., Mok, C. P. Y., Rowe, T., Zitzow, L. A., Karunakaran, K. P., Voss, T. G., Brunham, R. C., Gauldie, J., et al. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/001891-0 · Cited by 85
Zhi, Y., Kobinger, G., Jordan, H. M., Suchma, K., Weiss, S. R., Shen, H., Schumer, G., Gao, G., Boyer, J. L., Crystal, R. G., et al. (2005) · Virology · doi:10.1016/j.virol.2005.01.050 · Cited by 82
Immunological responses against SARS-coronavirus infection in humans.
XiaojunXu, & Xiao-MingGao (2004) · PubMed · Cited by 81
Zhou, T., Wang, H., Luo, D., Rowe, T., Wang, Z., Hogan, R. J., Qiu, S., Bunzel, R. J., Huang, G., Mishra, V., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7217-7226.2004 · Cited by 81
Li, T., Xie, J., He, Y., Fan, H., Baril, L., Qiu, Z., Han, Y., Xu, W.-B., Zhang, W., You, H., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000024 · Cited by 80
Self-citationWang, S., Chou, T.-H. W., Sakhatskyy, P. V., Huang, S., Lawrence, J. M., Cao, H., Huang, X., & Lu, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1906-1910.2005 · Cited by 80
Zakhartchouk, A. N., Sharon, C., Satkunarajah, M., Aupérin, T. C., Viswanathan, S., Mutwiri, G., Petric, M., See, R. H., Brunham, R. C., Finlay, B. B., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.084 · Cited by 79
Zhang, C.-Y., Wei, J., & He, S. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-88 · Cited by 73
Åkerström, S., Mirazimi, A., & Tan, Y. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.10.008 · Cited by 71
Zheng, B., Guan, Y., He, M., Sun, H., Du, L., Zheng, Y., Wong, K., Chen, H., Chen, Y., Lu, L., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000301 · Cited by 70
Self-citationCoughlin, M., Lou, G., Martinez, O., Masterman, S. K., Olsen, O. A., Moksa, A. A., Farzan, M., Babcook, J. S., & Prabhakar, B. S. (2007) · Virology · doi:10.1016/j.virol.2006.09.029 · Cited by 70
Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice
Jin, H., Xiao, C., Chen, Z., Kang, Y., Ma, Y., Zhu, K., Xie, Q., Tu, Y.-X., Yu, Y., & Wang, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.048 · Cited by 69
Mounting Lab Accidents Raise SARS Fears
Normile, D. (2004) · Science · doi:10.1126/science.304.5671.659 · Cited by 68
Sheahan, T. P., Rockx, B., Donaldson, E., Corti, D., & Baric, R. S. (2008) · Journal of Virology · doi:10.1128/jvi.00818-08 · Cited by 68
Che, X., Di, B., Zhao, G., Wang, Y., Qiu, L., Hao, W., Wang, M., Qin, P. Z., Liu, Y., Chan, K. C. A., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/504943 · Cited by 64
HUANG, J., CAO, Y., Du, J., Bu, X., MA, R., & Wu, C. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.047 · Cited by 63
Xiao Dong, W. U., Shang, B. Z., Rui Fu, Y. A. N. G., Yu, H., Zhi Hai, M. A., Shen, X., Ji, Y., Lin, Y. C., Ya Di, W. U., Guo Mei, L. I. N., et al. (2004) · Cell Research · doi:10.1038/sj.cr.7290240 · Cited by 62
He, Y., Li, J., Du, L., Yan, X., Hu, G., Zhou, Y., & Jiang, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.054 · Cited by 62
Self-citationRockx, B., Sheahan, T. P., Donaldson, E., Harkema, J. R., Sims, A. M., Heise, M. T., Pickles, R. J., Cameron, M. J., Kelvin, D. J., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.00505-07 · Cited by 62
Laboratory-acquired SARS raises worries on biosafety
Orellana, C. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00911-9 · Cited by 60
Hakansson-McReynolds, S., Jiang, S., Rong, L., & Caffrey, M. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601174200 · Cited by 60
Self-citationLai, S.-C., Chong, P. C.-S., Yeh, C., Liu, L. S.-J., Jan, J., Chi, H.-Y., Liu, H.-W., Chen, A., & Wang, Y.-C. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-9004-3 · Cited by 58
Liu, L., Fang, Q., Dèng, F., Wang, H., Yi, C. E., Ba, L., Yu, W., Lin, R. D., Li, T., Hú, Z., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02389-06 · Cited by 57
McRoy, W. C., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01674-07 · Cited by 47
Ujike, M., Nishikawa, H., Otaka, A., Yamamoto, N., Yamamoto, N., Matsuoka, M., Kodama, E. N., Fujii, N., & Taguchi, F. (2007) · Journal of Virology · doi:10.1128/jvi.01697-07 · Cited by 47
Du, L., He, Y., Wang, Y., Zhang, H., Ma, S., Wong, C. K. L., Wu, S., Ng, F., Huang, J., Yuen, K., et al. (2006) · Virology · doi:10.1016/j.virol.2006.03.049 · Cited by 46
Self-citationHe, M., Zheng, B.-J., Chen, Y., Wong, K., Huang, J., Lin, M. C. M., Peng, Y., Yuen, K., Sung, J. J. �., & Kung, H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.066 · Cited by 36
Self-citationA molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2
Zhang, Y., Zheng, N., Hao, P., Cao, Y., & Zhong, Y. (2005) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2005.04.008 · Cited by 36
DNA Vaccine of SARS-Cov S Gene Induces Antibody Response in Mice
Zhao, P., Ke, J.-S., Qin, Z.-L., Ren, H., Zhao, L.-J., Yu, J.-G., Gao, J., Zhu, S.-Y., & Qi, Z.-T. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.1.37 · Cited by 36
He, Y., Li, J., & Jiang, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.139 · Cited by 35
Self-citationVogel, L., Roberts, A., Paddock, C. D., Genrich, G. L., Lamirande, E. W., Kapadia, S. U., Rose, J. K., Zaki, S. R., & Subbarao, K. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.055 · Cited by 25
SARS-CoV, But not HCoV-NL63, Utilizes Cathepsins to Infect Cells: Viral Entry
Huang, I., Bosch, B., Li, W., Farzan, M., Rottier, P. J. M., & Choe, H. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-33012-9_60 · Cited by 23
Mitsuki, Y.-Y., Ohnishi, K., Takagi, H., Oshima, M., Yamamoto, T., Mizukoshi, F., Terahara, K., Kobayashi, K., Yamamoto, N., Yamaoka, S., et al. (2008) · Microbes and Infection · doi:10.1016/j.micinf.2008.05.009 · Cited by 21
SARS virus returns to China as scientists race to find effective vaccine.
Fleck, F. (2004) · PubMed · Cited by 19
From genome to antivirals: SARS as a test tube
Kliger, Y., Levanon, E. Y., & Gerber, D. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03320-3 · Cited by 17
Cited by
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., Yuen, K.-Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.045 · Cited by 2,892
“900 Cell 181, 894–904, May 14, 2020 teins have been shown to efficiently induce production of neutralizing antibodies (Du et al., 2009; Wang et al., 2016).”
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Coronavirus Disease 2019–COVID-19
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,876
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667
Metadata
- Authors
- Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S.
- Venue
- Nature Reviews Microbiology
- Published
- 2009-02-09
- Volume
- 7
- Issue
- 3
- Pages
- 226-236
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2012505332
- Cited by
- 1,661
- References
- 135
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.